Vascular and glymphatic dysfunction as drivers of cognitive impairment in Alzheimer's disease: Insights from

Gehan Fatima1, Akm Ashiquzzaman1, Sang Seong Kim1

  • 1Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Rep. of Korea.

PubMed

Insights

Alzheimer's disease involves vascular aging, impaired brain fluid clearance, and inflammation. New machine learning tools help analyze data to understand these connections for better diagnostics and treatments.

Area of Science:

  • Neuroscience
  • Vascular Biology
  • Biomedical Engineering

Background:

  • Alzheimer's disease (AD) pathogenesis involves intricate links between cerebrovascular dysfunction, impaired glymphatic system function, and neuroinflammation.
  • Vascular aging, marked by arterial stiffness and reduced cerebral blood flow (CBF), compromises the pulsatile forces essential for glymphatic clearance, leading to amyloid-beta (Aβ) buildup and cognitive decline.

Purpose of the Study:

  • To review the mechanistic interplay between vascular aging, glymphatic impairment, and neuroinflammation in Alzheimer's disease.
  • To explore the potential of machine learning (ML) tools in analyzing multimodal data for enhanced diagnostic precision in AD.

Main Methods:

  • Literature review synthesizing current research on the interconnectedness of vascular, glymphatic, and inflammatory systems in AD.
  • Exploration of machine learning applications, specifically DeepLabCut and Motion sequencing (MoSeq), for analyzing complex biological data.

Main Results:

  • Vascular aging significantly disrupts glymphatic clearance, promoting Aβ accumulation and cognitive deficits.
  • Machine learning tools show promise in integrating imaging and behavioral data to elucidate vascular-glymphatic dysfunction.

Conclusions:

  • Understanding the crosstalk between vascular dysfunction, glymphatic impairment, and neuroinflammation is crucial for AD pathogenesis.
  • Integrating advanced ML techniques with multimodal analyses offers a pathway to improved early diagnostics and targeted interventions for neurovascular health in AD.